公开(公告)号：US20190314272A1

公开(公告)日：2019-10-17

申请号：US16220442

申请日：2018-12-14

Applicant: Pfizer Inc.

Inventor： Advait Vijay Badkar ,  Leigh Kristen Bohack ,  Kevin Roger King ,  Atlanta Lea Lary

IPC: A61K9/00 ,  A61K47/26 ,  A61K31/198 ,  A61K47/18

Abstract: The present invention relates generally to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by a liquid formulation of a humanised anti-NGF antibody.

公开(公告)号：US20220175663A1

公开(公告)日：2022-06-09

申请号：US17378025

申请日：2021-07-16

Applicant: Pfizer Inc.

Inventor： Advait Vijay Badkar ,  Leigh Kristen Bohack ,  Kevin Roger King ,  Alanta Lea Lary

IPC: A61K9/00 ,  A61K31/198 ,  A61K47/18 ,  A61K47/26

Abstract: The present invention relates generally to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by a liquid formulation of a humanised anti-NGF antibody.